SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001213900-23-000325
Filing Date
2023-01-03
Accepted
2023-01-03 15:05:50
Documents
1
Period of Report
2023-01-01

Document Format Files

Seq Description Document Type Size
1 ownership.html 3  
1 ownership.xml 3 3162
  Complete submission text file 0001213900-23-000325.txt   4562
Mailing Address JERUSALEM BIOPARK, 2ND FLOOR HADASSAH EIN KEREM CAMPUS JERUSALEM L3 00000
Business Address JERUSALEM BIOPARK, 2ND FLOOR HADASSAH EIN KEREM CAMPUS JERUSALEM L3 00000 972-8-9302529
BiondVax Pharmaceuticals Ltd. (Issuer) CIK: 0001611747 (see all company filings)

IRS No.: 000000000 | State of Incorp.: L3 | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address 269 NAHAL FARAN ST. TAL SHAHAR L3 7680500
Business Address
Reichman Amir (Reporting) CIK: 0001960199 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-37353 | Film No.: 23501751